BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients

Isocitrate dehydrogenase 1 (IDH1)-wildtype glioblastoma (GBM) has found to be accompanied with increased expression of branched-chain amino acid trasaminase1 (BCAT1), which is associated with tumor growth and disease progression. In this retrospective study, quantitative RT-PCR, immunohistochemistry...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hye Rim, Jeon, Hyejin, Park, Chul-Kee, Park, Sung-Hye, Kang, Koung Mi, Choi, Seung Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735129/
https://www.ncbi.nlm.nih.gov/pubmed/29255149
http://dx.doi.org/10.1038/s41598-017-17062-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735129/
https://www.ncbi.nlm.nih.gov/pubmed/29255149
http://dx.doi.org/10.1038/s41598-017-17062-1

Ejemplares similares